Accession Number ADA564162
Title Induced Pluripotent Stem Cells as Potential Therapeutic Agents in NF1.
Publication Date May 2012
Media Count 9p
Personal Author J. Chernoff
Abstract In this project, we are seeking to use induced pluripotent stem (iPS) cell technology as a potential therapy in NF1. In the first years, we have successfully produced iPS cells from fobroblasts from Nf1 +/-mice and characterized the properties of these cells, which include growth in clusters, expression of stem cell markers, normal karyotype, and the ability to form teratomas in mice. We also created a targeting 'gene-repair' vector and have used this vector to to replace the defective Nf1 allele in these iPS cells. We then showed that we could differentiate iPS cells into Schwann-like cells in vitro, enabling drug sensitivity studies.
Keywords Blood cells
Chemotherapeutic agents
Defects(Materials)
Differentiation
Drugs
Gene targeting
Growth(Physiology)
Hematopoietic cells
Ips(Induced pluriopotent stem)
Nf1(Neurofibromatosis 1)
Schwann cells
Stem cells
Vector analysis


 
Source Agency Non Paid ADAS
NTIS Subject Category 57B - Biochemistry
57E - Clinical Medicine
Corporate Author Institute for Cancer Research, Philadelphia, PA.
Document Type Technical report
Title Note Final rept. 1 May 2010-30 Apr 2010.
NTIS Issue Number 1302
Contract Number W81XWH-10-1-0181

Science and Technology Highlights

See a sampling of the latest scientific, technical and engineering information from NTIS in the NTIS Technical Reports Newsletter

Acrobat Reader Mobile    Acrobat Reader